Online Only Articles

In response to the comment by Hechler et al.: Amotosalen/UVA pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance.

Laboratory for Platelet Research, Center for Molecular Cardiology, University of Zurich, Switzerland
Laboratory for Platelet Research, Center for Molecular Cardiology, University of Zurich, Switzerland
Regional Service of the Swiss Red Cross, University Hospital Basel, Switzerland
Internal Medicine, Cantonal Hospital of Baden, Switzerland
Laboratory for Platelet Research, Center for Molecular Cardiology, University of Zurich, Switzerland
Hematology, University Hospital Basel, Switzerland
Laboratory for Platelet Research, Center for Molecular Cardiology, University of Zurich, Switzerland
Laboratory for Platelet Research, Center for Molecular Cardiology, University of Zurich, Switzerland
Regional Service of the Swiss Red Cross, University Hospital Basel, Switzerland
Laboratory for Platelet Research, Center for Molecular Cardiology, University of Zurich, Switzerland;Internal Medicine, Cantonal Hospital of Baden, Switzerland
Vol. 102 No. 12 (2017): December, 2017 https://doi.org/10.3324/haematol.2017.181818